Nicox and Kowa Enter into Agreement for NCX 470
08 Feb 2024 //
GLOBENEWSWIRE
Kowa Pharma to Publish PIII Data Supporting FDA Approval of SEGLENTIS
19 Jul 2022 //
BUSINESSWIRE
Kowa To Discontinue K-877 (Pemafibrate) "Prominent" CVS Outcomes Study
08 Apr 2022 //
PRNEWSWIRE